glp 1 drugs and hair loss ARE YOU ON A GLP-1 EXPERIENCING LOSS? If this is you read this 👇🏼 GLP-1 medications (like semaglutide or tirzepatide) are widely used for weight and diabetes—but some people GLP-1 Medications and Hair Loss:

Description

PubMed CrossRef Moiz A, Filion KB, Tsoukas MA, et al

A significant portion of this growth is attributed to the rapid rise of GLP-1 medications drugs initially developed for diabetes treatment that are now widely used for weight loss

Consistent with other GLP-1 agonists, orforglipron labeling is expected to include the standard boxed warning about thyroid C-cell tumors and a contraindication in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Front Physiol 12:785879 Martens P, Mathieu C, Vanassche T (2023) The use of glucagon-like-peptide-1 receptor agonist in the cardiology practice

Key points: GLP-1s (glucagon-like peptide-1 receptor agonists) support type 2 diabetes by reducing appetite and supporting weight loss alongside their effects on the pancreas GLP-1-assisted programmes lead to a clinically significant weight loss of 10% or more, which can significantly reduce complications associated with obesity Combining semaglutide with lifestyle interventions leads to significantly more weight loss than lifestyle interventions alone, with 87% of participants losing more than 10% of their body weight Semaglutide is more effective at supporting weight loss than liraglutide Tirzepatide is more effective than semaglutide at reducing weight, with all three doses of tirzepatide leading to more significant weight loss than 1mg of semaglutide The higher doses of tirzepatide (10mg and 15mg) might reduce weight by 5.15kg more than 2mg of semaglutide, while there appears to be no difference between 5mg of tirzepatide and 2mg of semaglutide 3) Side effects and safety All medications have possible side effects, particularly if you live with other health conditions